Achieve Life Sciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $228 |
Gross Profit | -55 | -62 | 114 | |
EBITDA | -14,194 | -12,472 | -12,580 | -12,105 |
EBIT | -14,249 | -12,527 | -12,642 | -12,163 |
Net Income | -14,441 | -12,718 | -12,827 | -12,360 |
Net Change In Cash | 0 | 0 | 0 | 228 |
Free Cash Flow | -11,331 | -9,069 | -11,088 | -9,189 |
Cash | 31,930 | 51,874 | 13,016 | 12,733 |
Basic Shares | 34,685 | 34,685 | 34,685 | 34,510 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -229 | -228 | -236 | -250 |
EBITDA | -37,418 | -26,734 | -40,564 | -32,844 |
EBIT | -37,647 | -26,962 | -40,800 | -33,094 |
Net Income | -39,827 | -29,815 | -41,875 | -32,902 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -18,254 | |||
Free Cash Flow | -29,770 | -24,500 | -37,569 | -29,440 |
Cash | 12,733 | 15,546 | 24,721 | 43,022 |
Basic Shares | 32,071 | 19,827 | 10,593 | 8,119 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.28 |
2025-06-30 | -$0.37 |
2025-03-31 | -$0.37 |
2024-12-31 | -$0.36 |
